Get Connected:

The MD Magazine Dermatology specialty page provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

Latest Headlines

Biologics for Long-Term Treatment of Psoriasis Generally Safe
A German cohort study in Archives of Dermatological Research found that antipsoriatic drugs for treatment of moderate-to-severe psoriasis are generally safe over the long-term.
A recently published article in JAMA Dermatology explored the curious relationship between psoriasis and depression, since psoriasis has been considered a risk factor for depression, and depression a trigger for psoriasis.
Phototherapy with ultraviolet A-1 (UVA-1) has been considered a promising treatment option for patients afflicted with alopecia areata.
Patients with advanced melanoma are living longer when treated with a combination of two targeted therapies, dabrafenib and trametinib than those solely given another drug, vemurafenib.
Pachyonychia congenita (PC), a rare skin disorder, can cause an inordinate amount of neuropathic pain, a study in Clinical and Experimental Dermatology confirms. In the chilling words used by the researchers, “The health states observed in this sample are at a level that the average US citizen would forfeit one-third of their remaining lifespan to avoid.”
Treating moderate to severe plaque psoriasis is certainly no picnic for patients’ pockets.
Individuals afflicted with psoriasis and psoriatic arthritis are also at higher risk for new-onset migraines.

Most Popular in Dermatology

Recent Published Journal

$vacMongoViewPlus$ $vAR$